title: [Volume retention in heart failure, nephrotic syndrome, and liver cirrhosis].
abstract: Volume retention in heart failure, nephrotic syndrome, and liver cirrhosis reflects pathological changes in homeostatic mechanisms that regulate the extracellular volume (sympathetic activity, renin-angiotensin-aldosterone system [RAAS], natriuretic peptides) and plasma osmolality (antidiuretic hormone [ADH]). In heart failure and liver cirrhosis, these changes are induced by a reduction of the effective circulating volume, which is the part of the extracellular fluid that is within the arterial system and effectively perfusing the tissues. This reduction in the effective circulating volume is caused by reduced cardiac output (heart failure), or by splanchnic vasodilatation with arterial underfilling (liver cirrhosis). In both cases, baroreceptors in both the carotid sinuses and in the glomerular afferent arterioles upregulate RAAS- and sympathetic activity, resulting in systemic vasoconstriction and renal sodium (and volume) retention. More severe reductions in the effective circulating volume may additionally stimulate ADH release, thus increasing the reabsorption of free water with subsequent hyponatriemia. In nephrotic syndrome, volume retention results either directly from the primary renal disease, which induces renal sodium and volume retention ("overfilling"), or indirectly from the reduced plasma oncotic pressure due to hypoalbuminemia, which induces a fluid shift from the intravascular to the interstitial space ("underfilling") with subsequent acitivation of baroreceptors and secondary sodium and volume retention.
authors.affiliation: Medizinische Klinik IV, Universitätsklinikum des Saarlandes, Homburg, Saar. inghei@uniklinik-saarland.de
authors.forename: G H
authors.initials: GH
authors.lastname: Heine
authors.forename: U
authors.initials: U
authors.lastname: Sester
authors.forename: H
authors.initials: H
authors.lastname: Köhler
mesh_terms: D001810:Blood Volume; D001834:Body Water; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000503:physiopathology*; D008954:Models, Biological; D009404:Nephrotic Syndrome / Q000150:complications / Q000503:physiopathology*; D012084:Renin-Angiotensin System; D014882:Water-Electrolyte Balance; D014883:Water-Electrolyte Imbalance / Q000503:physiopathology*